This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Federal Register. E.O. 13676. 79 FR 56931 (2014).
Applications for FDA Approval to Market a New Drug. 21 CFR §314.126 (2009).
Hwang, T.J., Carpenter, D. & Kesselheim, A.S. Science 344, 967–969 (2014).
Floyd, J.S. & Psaty, B.M. JAMA Intern. Med. 174, 1436–1437 (2014).
Outterson, K. et al. J. Law Med. Ethics 41, 688–696 (2013).
Kesselheim, A.S., Connolly, J., Rogers, J. & Avorn, J. Health Aff. (Millwood) 34, 438–446 (2015).
Silver, L.L. Nat. Biotechnol. 32, 1102–1104 (2014).
Falagas, M.E. Emerg. Infect. Dis. 20, 1170–1175 (2014).
Darrow, J.J., Avorn, J. & Kesselheim, A.S. N. Engl. J. Med. 371, 89–90 (2014).
Kesselheim, A.S. & Outterson, K. Yale J. Health Policy Law Ethics 11, 101–167 (2011).
Sertkaya, A. et al. Eastern Research Group Report for the US Department of Health and Human Services, report no. HHSP23337004T (ERG, Washington, DC, (2014).
Hwang, T.J., Carpenter, D. & Kesselheim, A.S. Sci. Transl. Med. 7, 276fs9 (2015).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Figure
Supplementary Figure 1 (PDF 304 kb)
Rights and permissions
About this article
Cite this article
Hwang, T., Powers, J., Carpenter, D. et al. Accelerating innovation in rapid diagnostics and targeted antibacterials. Nat Biotechnol 33, 589–590 (2015). https://doi.org/10.1038/nbt.3251
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3251
This article is cited by
-
Why microbial diagnostics need more than money
Nature Biotechnology (2015)